Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Izumi K, Li L, Chang C.

Clin Investig (Lond). 2014 Oct 1;4(10):935-950.

2.
3.

Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network.

Curro FA, Robbins DA, Naftolin F, Grill AC, Vena D, Terracio L.

Clin Investig (Lond). 2015;5(2):145-159.

4.

Data fraud in clinical trials.

George SL, Buyse M.

Clin Investig (Lond). 2015;5(2):161-173.

5.
6.

An evaluation of recruitment methods utilized for a clinical trial with periodontal and diabetes enrollment criteria: the Diabetes and Periodontal Therapy Trial.

Schoenfeld ER, Hyman L, Simpson LL, Michalowicz B, Reddy M, Gelato M, Hou W, Engebretson SP, Hytner C, Lenton P; the DPTT Study Group.

Clin Investig (Lond). 2014 Dec 1;4(12):1065-1081.

7.

How can we manage resistance to antiangiogenic drugs?

Luu DC, Chao J.

Clin Investig (Lond). 2014;4(6):483-486. No abstract available.

8.
9.

Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.

Konstan MW, Borowitz D, Mayer-Hamblett N, Milla C, Hendeles L, Murray S, Kronmal RA, Casey S, Rose LM, Morgan WJ, Ramsey BW.

Clin Investig (Lond). 2013 Aug;3(8):731-741.

10.

Measuring symptoms as a critical component of drug development and evaluation in hematological diseases.

Williams LA, Yucel E, Cortes JE, Cleeland CS.

Clin Investig (Lond). 2013 Dec 1;3(12):1127-1138.

11.

Noninferiority trials: clinical understandings and misunderstandings.

Powers JH, Fleming TR.

Clin Investig (Lond). 2013 Mar 1;3(3):215-218. No abstract available.

12.

Novel treatment options for ulcerative colitis.

Vaughn BP, Moss AC.

Clin Investig (Lond). 2013 Nov;3(11):1057-1069.

13.

HIV PrEP Trials: The Road to Success.

Nicol MR, Adams JL, Kashuba AD.

Clin Investig (Lond). 2013 Mar;3(3). doi: 10.4155/cli.12.155.

14.

Outcome measures in amyotrophic lateral sclerosis clinical trials.

Paganoni S, Cudkowicz M, Berry JD.

Clin Investig (Lond). 2014;4(7):605-618.

15.

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia.

Devidas M, Anderson JR.

Clin Investig (Lond). 2013 Sep;3(9). doi: 10.4155/cli.13.71.

16.

Genetic biomarkers of placebo response: what could it mean for future trial design?

Hall KT, Kaptchuk TJ.

Clin Investig (Lond). 2013 Apr 1;3(4):311-314. No abstract available.

17.

Novel oral taxane therapies: recent Phase I results.

Flores JP, Saif MW.

Clin Investig (Lond). 2013;3(4):333-341.

18.

Treatment of Clostridium difficile infection: recent trial results.

Lewis SS, Anderson DJ.

Clin Investig (Lond). 2013;3(9):875-886.

19.

Rethinking Phase II Clinical Trial Design in Heart Failure.

Lavine KJ, Mann DL.

Clin Investig (Lond). 2013 Jan 1;3(1):57-68.

20.

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

Kublin JG, Morgan CA, Day TA, Gilbert PB, Self SG, McElrath MJ, Corey L.

Clin Investig (Lond). 2012 Mar;2(3):245-254.

Supplemental Content

Loading ...
Support Center